Manish Kohli
( out of 43 reviews )

Manish Kohli, MD

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Patient Rating

    4.9 /5
    ( out of 43 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 18, 2024
    HUNTSMAN CANCER CENTER

    He was very good and I appreciated his time. I just wish that my chart would have been looked at earlier so that I would have gone to Dr Johnson this trip instead on having to make and extra trip to SLC from Pleasant Grove

    August 16, 2024
    HUNTSMAN CANCER CENTER

    Dr. Kohli is awesome!! Very knowledgeable and caring.

    August 11, 2024
    HUNTSMAN CANCER CENTER

    I would recommend Doctor Kohli and his team to everyone. They truly want to help and care about the patients needs.

    August 09, 2024
    HUNTSMAN CANCER CENTER

    a very nice Doctor and a wonderful person

    July 05, 2024
    HUNTSMAN CANCER CENTER

    How would you recommend him to any patient that has cancer?He does a great job

    June 07, 2024
    HUNTSMAN CANCER CENTER

    He's just a very rarely good he cares about the patience very well I would recommend him to others

    May 25, 2024
    HUNTSMAN CANCER CENTER

    Very professional and carring

    May 17, 2024
    HUNTSMAN CANCER CENTER

    Best Doctor and staff, best ever

    May 06, 2024
    HUNTSMAN CANCER CENTER

    Muy paciente y explica todo con eficiencia.

    See More Patient Comments

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Oncology

  • News & Podcasts

    Huntsman Cancer Institute News